This case emphasizes the significance of recognizing ICI-related hepatitis as a potential form of DILI in patients who exhibit elevated ALT levels indicative of grade 4 ICI-related hepatitis risk, in line with the 2022 National Comprehensive Cancer Network (NCCN) guidelines (Thompson et al., 2022). The gene discussed is GPT; the disease is hepatitis A virus infection.